Page last updated: 2024-12-11

osthenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

osthenol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

osthenol : A hydroxycoumarin that is umbelliferone in which the hydrogen at position 8 has been replaced by a prenyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5320318
CHEMBL ID350475
CHEBI ID81485
SCHEMBL ID51013
MeSH IDM0295789

Synonyms (40)

Synonym
nsc-625328
nsc625328
osthenol
NCI60_007807
ACON1_000810
MEGXP0_000219
ostenol
7-hydroxy-8-(3-methyl-2-butenyl)-2h-1-benzopyran-2-one
bdbm50240868
7-hydroxy-8-(3-methyl-but-2-enyl)-chromen-2-one
BRD-K53399718-001-01-8
484-14-0
C18080
CHEMBL350475 ,
chebi:81485 ,
7-hydroxy-8-(3-methylbut-2-enyl)chromen-2-one
unii-7x6rf2708x
7x6rf2708x ,
2h-1-benzopyran-2-one, 7-hydroxy-8-(3-methyl-2-butenyl)-
coumarin, 7-hydroxy-8-(3-methyl-2-butenyl)-
7-hydroxy-8-isopent-2-enylcoumarin
7-hydroxy-8-prenylcoumarin
SCHEMBL51013
7-hydroxy-8-(3-methyl-but-2-enyl)coumarin
8-(3-methylbut-2-en-1-yl)umbelliferone
8-prenylumbelliferone
7-hydroxy--2h-1-benzopyran-2-one
7-hydroxy-8-(3-methylbut-2-en-1-yl)-2h-chromen-2-one
AKOS025402390
DTXSID80197508
AC-8807
7-hydroxy-8-(3-methyl-2-butenyl)-2h-1-benzopyran-2-one, 9ci
BCP24741
Q27155413
mfcd03427690
7-hydroxy-8-prenylcoumarin; nsc 625328
FT-0777401
MS-23307
CS-0022826
HY-N2554
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxycoumarinAny coumarin carrying at least one hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)IC50 (µMol)25.30000.00000.94539.9400AID1624339
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)0.74000.00002.37899.7700AID1624337
Amine oxidase [flavin-containing] AHomo sapiens (human)Ki0.26000.00192.379710.0000AID1624340
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)64.00000.00021.557410.0000AID403341
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)60.00000.00001.89149.5700AID1624338
Beta-secretase 1Homo sapiens (human)IC50 (µMol)500.00000.00061.619410.0000AID637774
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (37)

Processvia Protein(s)Taxonomy
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (19)

Processvia Protein(s)Taxonomy
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (30)

Processvia Protein(s)Taxonomy
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID1624335Inhibition of human recombinant MAO-A expressed in baculovirus infected BTI insect cells using kynuramine as substrate assessed as residual activity at 10 uM after 20 mins by spectrophotometric analysis relative to control2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID378959Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio relative to TPA2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID1624340Competitive inhibition of human recombinant MAO-A expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by Lineweaver-Burk plot analysis2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID637774Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID357623Antiplatelet activity against washed rabbit platelet assessed as inhibition of collagen-induced platelet aggregation at 50 ug/mL pre-incubated 3 mins before collagen challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID1151356Antiinflammatory activity in human neutrophil assessed as inhibition of FMLP/CB-induced elastase release for 5 mins2014Journal of natural products, May-23, Volume: 77, Issue:5
Constituents of the roots of Clausena lansium and their potential anti-inflammatory activity.
AID357617Antiplatelet activity against washed rabbit platelet assessed as inhibition of arachidonic acid-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before arachidonic acid challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID378961Inhibition of TPA-induced EBV-early antigen activation in human Raji cells2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID1624339Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 15 mins followed by substrate addition by Ellman's method2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID1624337Inhibition of human recombinant MAO-A expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by spectrophotometric analysis2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID1624349Reversible inhibition of human recombinant MAO-A expressed in baculovirus infected BTI insect cells assessed as residual activity at 1.5 uM incubated for 30 mins using kynuramine as substrate by spectrophotometric analysis relative to control2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID378960Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID1624338Inhibition of human recombinant MAO-B expressed in baculovirus infected BTI insect cells using benzylamine as substrate after 30 mins by spectrophotometric analysis2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID378956Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio relative to TPA2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID357625Antiplatelet activity against washed rabbit platelet assessed as inhibition of platelet activating factor-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before PAF challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID1624350Reversible inhibition of human recombinant MAO-A expressed in baculovirus infected BTI insect cells assessed as residual activity at 1.5 uM incubated for 30 mins followed by dialysis using kynuramine as substrate by spectrophotometric analysis relative to2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID378962Scavenging activity against (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide-induced NO generation in human Chang liver cells2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID403341Inhibition of COX12005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID357618Antiplatelet activity against washed rabbit platelet assessed as inhibition of arachidonic acid-induced platelet aggregation at 50 ug/mL preincubated 3 mins before arachidonic acid challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID378958Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio relative to TPA2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID1151355Antiinflammatory activity in human neutrophil assessed as inhibition of FMLP/CB-induced superoxide anion generation pretreated for 5 mins by spectrophotometry2014Journal of natural products, May-23, Volume: 77, Issue:5
Constituents of the roots of Clausena lansium and their potential anti-inflammatory activity.
AID357614Antiplatelet activity against washed rabbit platelet assessed as inhibition of thrombin-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before thrombin challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID357622Antiplatelet activity against washed rabbit platelet assessed as inhibition of collagen-induced platelet aggregation at 100 ug/mL pre-incubated 3 mins before collagen challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID1624336Inhibition of human recombinant MAO-B expressed in baculovirus infected BTI insect cells using benzylamine as substrate assessed as residual activity at 10 uM after 30 mins by spectrophotometric analysis relative to control2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
AID637775Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
AID378957Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio relative to TPA2006Journal of natural products, Jan, Volume: 69, Issue:1
Chalcones and other compounds from the exudates of Angelica keiskei and their cancer chemopreventive effects.
AID140324Compound was tested for the inhibitory activity against mouse macrophage RAW 264.7 cells at the concentration of 50 uM; Inactive2000Bioorganic & medicinal chemistry letters, Jan-03, Volume: 10, Issue:1
1,1-Dimethylallylcoumarins potently suppress both lipopolysaccharide- and interferon-gamma-induced nitric oxide generation in mouse macrophage RAW 264.7 cells.
AID357624Antiplatelet activity against washed rabbit platelet assessed as inhibition of collagen-induced platelet aggregation at 20 ug/mL pre-incubated 3 mins before collagen challenge by turbidimetric method2001Journal of natural products, Sep, Volume: 64, Issue:9
Quinoline alkaloids and other constituents of Melicope semecarpifolia with antiplatelet aggregation activity.
AID1624341Selectivity index, ratio of IC50 for human recombinant MAO-B expressed in baculovirus infected BTI insect cells to IC50 for human recombinant MAO-A expressed in baculovirus infected BTI insect cells2019Bioorganic & medicinal chemistry letters, 03-15, Volume: 29, Issue:6
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's5 (45.45)29.6817
2010's4 (36.36)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.82 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.72 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]